Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
The Deep Dementia Phenotyping (DEMON) Network: A global platform for innovation using data science and artificial intelligence
1
Zitationen
28
Autoren
2022
Jahr
Abstract
Abstract Background The increasing availability of large high‐dimensional data from experimental medicine, population‐based and clinical cohorts, clinical trials, and electronic health records has the potential to transform dementia research. Our ability to make best use of this rich data will depend on utilisation of advanced machine learning and artificial intelligence (AI) techniques and collaboration across disciplinary and geographic boundaries. Method The Deep Dementia Phenotyping (DEMON) Network launched in 2019 1 to support the growing interest in machine learning and AI. Led by Director Prof David Llewellyn and Deputy Director Dr Janice Ranson, the leadership team additionally includes 5 Theme Leads and 14 Working Group Leads, supported by an international Steering Committee of world‐leading academics. Core funding is provided by Alzheimer’s Research UK, the Alan Turing Institute and the University of Exeter, with additional support from strategic partners including the UK Dementia Research Institute and the Alzheimer’s Society. Grand Challenges were established at a National Strategy Workshop in June 2020. Multidisciplinary Working Groups were formed to coordinate practical activities in seven key areas: Genetics and omics, experimental medicine, drug discovery and trials optimisation, biomarkers, imaging, dementia prevention, and applied models and digital health. Additional Special Interest Groups coordinate topic specific collaborations. Result Membership on 4th February 2022 comprised 1,321 individuals from 61 countries across 6 continents (see Figure). Areas of expertise include dementia research (904; 68%), data science (692; 52%), clinical practice (244; 18%), industry (162; 12%), and regulation (26; 2%). Individual membership is free, and regular knowledge transfer events are provided including a monthly seminar series, talks and workshops, training, networking, and early career development. Each Working Group meets monthly, with multiple grants, reviews, and original research articles in progress. Eight state of the science position papers are in preparation, resulting from a Symposium held in April 2021. In January 2022, 110 early career researchers participated in the Network’s flagship event ‘NEUROHACK’, a 4‐day competitive global hackathon, with pilot grants awarded to those generating the most innovative solutions. Conclusion The DEMON Network is a rapidly growing global platform for innovation that is supporting the global dementia research community to collaborate. Find out more at demondementia.com
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.214 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.071 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.429 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.776 Zit.
Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI)
2018 · 5.418 Zit.
Autoren
- Janice M. Ranson
- Ahmad Al Khleifat
- Donald M. Lyall
- Danielle Newby
- Laura Winchester
- Petroula Proitsi
- Michele Veldsman
- Timothy Rittman
- Sarah J. Marzi
- Zhi Yao
- Nathan Skene
- Conceição Bettencourt
- Andrey Kormilitzin
- Isabelle F. Foote
- Cecilia Golborne
- Ilianna Lourida
- Magda Bucholc
- Eugene Tang
- Neil P. Oxtoby
- Peter Bagshaw
- Zuzana Walker
- Richard Everson
- Clive Ballard
- Cornelia M. van Duijn
- Kenneth M. Langa
- Malcolm Macleod
- Kenneth Rockwood
- David J. Llewellyn
Institutionen
- University of Exeter(GB)
- King's College London(GB)
- University of Glasgow(GB)
- University of Oxford(GB)
- University of Cambridge(GB)
- UK Dementia Research Institute(GB)
- Imperial College London(GB)
- LifeArc(GB)
- University College London(GB)
- Queen Mary University of London(GB)
- University of Ulster(GB)
- Newcastle University(GB)
- Bath and North East Somerset Clinical Commissioning Group(GB)
- Bristol Clinical Commissioning Group(GB)
- The Alan Turing Institute(GB)
- University of Michigan–Ann Arbor(US)
- University of Edinburgh(GB)
- Dalhousie University(CA)